Physician profile
James E Sturmi
NPI 1922022748
$900.73
in general payments reported to CMS, 2019-2025
9 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Addiction Medicine (Internal Medicine) provider received nationally (typical 2025 total: $124).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $33.52 · 2021: $55.36 · 2022: $77.37 · 2023: $358 · 2024: $45.54 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $585.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $296.21 | 2022-2023 | Descovy, Epclusa |
| Alkermes, INC. | $213.76 | 2019-2021 | |
| Braeburn INC. | $198.55 | 2024-2025 | Brixadi |
| Almatica Pharma LLC | $60.27 | 2023 | Gralise |
| Indivior INC. | $40.48 | 2019-2024 | Sublocade |
| Abbvie INC. | $39.58 | 2022-2023 | Mavyret |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Orexo US, INC. | $17.91 | 2022 | |
| Uswm, LLC | $12.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Sturmi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.